Medical Terahertz Technology Market is expected to reach US$ 349.00 Million by 2028

In 2022, Terahertz Imaging Segment to Dominate Medical Terahertz Technology Market

According to The Insight Partners research study on "Medical Terahertz Technology Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type and Application," the market is expected to grow from US$ 135.29 million in 2022 to US$ 349.00 million by 2028; it is estimated to grow at a CAGR of 17.1% from 2022 to 2028. The rising demand for noninvasive techniques for the early detection of cancer and the increasing use of terahertz technology in dental care are the factors that contribute to the medical terahertz technology market growth. However, challenges related to imaging resolution restrict the market growth.

The COVID-19 epidemic is predicted to witness growth in the terahertz technology business, which finds its main uses in security, biomedicine, and healthcare. People with moderate symptoms are less likely to get tested because there is a limited supply of COVID-19 medical devices. The routine and preventative screenings were delayed due to the onset of the pandemic which postponed the detection and treatment of diseases. However, there was a sharp decline in the screening procedure and elective surgeries. Dental, skin, and cancer treatments were the hardest hit due to the pandemic. After people were vaccinated, the medical device industry and diagnostic imaging gradually returned to their normal operation. Moreover, research indicates that terahertz-based biosensors have the potential for low-cost, non-invasive, and rapid diagnosis of COVID-19 infection which boosted the medical terahertz technology market.

Based on application, the medical terahertz technology market is segmented into oncology, dentistry, dermatology, tomography, biochemistry, and others. The oncology segment is expected to hold the largest share of the market in 2022. Moreover, the same segment is anticipated to register the highest CAGR during the forecast period. Terahertz (THz) waves are electromagnetic waves with frequencies ranging from 0.1 THz to 10 THz. Owing to their low ionization energy and ability to distinguish the majority of proteins based on their spectrum fingerprints, THz waves offer enormous potential in the biomedical area, particularly in cancer diagnosis. The patient survival rate can be significantly improved if tumors can be identified and categorized early. Spectroscopic biomarker detection and tissue imaging are the two contemporary clinical cancer diagnostic methods. THz waves are well suited for high-accuracy in vivo and ex vivo inspection of tissue while inflicting little harm to healthy cells due to their nonionizing, noninvasive, and strong penetration properties. Additionally, spectral fingerprinting with THz waves can be employed in the qualitative and quantitative examination of cancer biomarkers. THz imaging for cancer tissue can discriminate between diseased & peritumoral tissues and normal tissues, providing surgeons with more information that can be used to remove cancerous and peritumoral tissues.

The information obtained by THz-based scanning can prove beneficial in the care of cancer patients and, more crucially, in the early diagnosis of various solid tumors, because it can correctly differentiate between different types of molecules based on water content. According to GLOBOCAN, 19.3 million new cancer cases were reported in 2020, with ~10.0 million cancer deaths. In 2018, ~4.8 million new instances of gastrointestinal (GI) malignancies were diagnosed worldwide, with 3.4 million deaths. GI malignancies are responsible for 26% of global cancer incidence and 35% of cancer-related deaths. Recent advancements in medical imaging can substantially lead to improvements in the early detection and treatment of various clinical disorders. THz imaging devices can also aid in detecting early cancer before it becomes apparent or detectable by other means.

Acal BFi Limited, Advantest Corporation, Teraview limited, Toptica Photonics AG, Terasense Group Inc., Microtech Instrument Inc., Menlo Systems GmbH, HÜBNER GmbH & Co. KG, Luna Innovations Inc., and Insight Product Company are the key companies operating in the medical terahertz technology market.

Medical Terahertz Technology Market, by Region, 2022 (%)

---

Medical Terahertz Technology Market Dynamics 2021 to 2031

Download Free Sample

---

Medical Terahertz Technology Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Terahertz Imaging and Terahertz Spectroscopy), Application (Oncology, Dentistry, Dermatology, Tomography, Biochemistry, and Others), and Geography

The report segments the medical terahertz technology market as follows:

The medical terahertz technology market is segmented on the basis of type, application, and geography. Based on type, the market is bifurcated into terahertz imaging and terahertz spectroscopy. Based on application, the medical terahertz technology market is segmented into oncology, dentistry, dermatology, tomography, biochemistry, and others. By geography, the medical terahertz technology market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).